What you need to know about new PAH therapy sotatercept
Автор: Pulmonary Hypertension Association (PHA UK)
Загружено: 2022-11-21
Просмотров: 5865
The new #PulmonaryArterialHypertension therapy sotatercept, which could be approved for use next year, has produced further positive results in its latest clinical trial. We spoke to Dr Mark Toshner, PH Specialist and Associate Professor, to get the facts about this promising drug - which is the first to target the root cause of the disease.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: